Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Immunohistochemical analysis of ezrin-radixin-moesin-binding phosphoprotein 50 in prostatic adenocarcinoma.

Bartholow TL, Becich MJ, Chandran UR, Parwani AV.

BMC Urol. 2011 Jun 14;11:12. doi: 10.1186/1471-2490-11-12.

2.

Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.

Epstein JI, Egevad L, Humphrey PA, Montironi R; Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group.

Am J Surg Pathol. 2014 Aug;38(8):e6-e19. doi: 10.1097/PAS.0000000000000238.

PMID:
25029122
3.

Roles of NHERF1/EBP50 in cancer.

Georgescu MM, Morales FC, Molina JR, Hayashi Y.

Curr Mol Med. 2008 Sep;8(6):459-68. Review.

PMID:
18781953
4.

The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.

De Nunzio C, Kramer G, Marberger M, Montironi R, Nelson W, Schröder F, Sciarra A, Tubaro A.

Eur Urol. 2011 Jul;60(1):106-17. doi: 10.1016/j.eururo.2011.03.055. Epub 2011 Apr 9. Review.

PMID:
21497433

Supplemental Content

Support Center